Ben Yong Insider Profile
4 Followers
Ben Yong, Chief Med & Dev Officer at BridgeBio Oncology Therapeutics, holds 44.58K shares in BridgeBio Oncology Therapeutics (Ticker: BBOT), holds 11.38K shares in Corbus Pharmaceuticals (Ticker: CRBP).
Ben Yong has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ben Yong holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ben Yong
Ben Yong's Trading History
BridgeBio Oncology Therapeutics
Jul 06, 2026
Chief Med & Dev Officer
Uninformative Sell
8.17K
$400.29K
Corbus Pharmaceuticals
May 21, 2026
Director
Uninformative Buy
―
$126.12K
List of latest transactions for each holding click on a transaction to see Ben Yong's performance on stock
You May Also Like
Ben Yong insider profile FAQ
What is the percentage of profitable transactions made by Ben Yong?
The percentage of profitable transactions made by Ben Yong is ―.
What is the average return per transaction made by Ben Yong?
The average return per transaction made by Ben Yong is ―.
What stocks does Ben Yong hold?
Ben Yong holds: BBOT, CRBP stocks.
What was Ben Yong’s latest transaction?
Ben Yong latest transaction was an Uninformative Sell of $8.17K.
What was Ben Yong's most profitable transaction?
Ben Yong’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ben Yong's role in BridgeBio Oncology Therapeutics?
Ben Yong's role in BridgeBio Oncology Therapeutics is Chief Med & Dev Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.